Merry Christmas and a Happy New Year
The year 2023 is slowly coming to an end. Therefore, as usual at this point, I would like to wish my readers a blessed Christmas season, as well as luck and health for the coming
Continue reading
Tag: BTKi
ECTRIMS 2023 in Milan – “We are halfway home, but we are not all the way there”
This year’s annual meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) took place from October 12 to 14 in Milan. This most important scientific MS congress discusses the most important
Continue reading
MS-Docblog – Details on the New Class of Active Substances of BTKi
Bruton tyrosine kinase inhibitors, or BTKi for short, are by no means new. They are known from cancer therapy and have been adapted for the treatment of neurologically degenerative diseases. So, will there soon be
Continue reading
ECTRIMS 2021 (3): New Therapeutic Concepts
One of the most exciting topics of large international congresses is the outlook for new therapies that may be able to bring added value in the future. As an immunological treatment strategy, we will probably
Continue reading
